{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:44:30Z","timestamp":1764895470820,"version":"3.46.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:00:00Z","timestamp":1759536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10072-025-08518-8","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:58:57Z","timestamp":1759543137000},"page":"7019-7020","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glatiramer acetate versus interferon \u03b2-1a: rethinking first-line therapy in pediatric-onset multiple sclerosis for greater relapse control"],"prefix":"10.1007","volume":"46","author":[{"given":"Talha","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2730-9740","authenticated-orcid":false,"given":"Rehman","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasnain Wajeeh","family":"Saqib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hashaam Jahangir","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Sarim","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,4]]},"reference":[{"key":"8518_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-025-08377-3","author":"M Simone","year":"2025","unstructured":"Simone M, Palumbi R, Achille M et al (2025) A multicentre, prospective, randomized, open-label pragmatic trial to compare the effectiveness and safety of interferon beta-1a and glatiramer-acetate in paediatric patients affected by multiple sclerosis. Neurol Sci. https:\/\/doi.org\/10.1007\/s10072-025-08377-3","journal-title":"Neurol Sci"},{"issue":"11","key":"8518_CR2","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1056\/NEJMoa1800149","volume":"379","author":"T Chitnis","year":"2018","unstructured":"Chitnis T, Arnold DL, Banwell B et al (2018) Trial of fingolimod versus interferon beta-1a in pediatric multiple sclerosis. N Engl J Med 379(11):1017\u20131027","journal-title":"N Engl J Med"},{"issue":"5","key":"8518_CR3","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S2352-4642(24)00047-6","volume":"8","author":"S Sharmin","year":"2024","unstructured":"Sharmin S, Roos I, Malpas CB et al (2024) Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis: a longitudinal analysis of global and national registries. Lancet Child Adolesc Health 8(5):348\u2013357","journal-title":"Lancet Child Adolesc Health"},{"issue":"3","key":"8518_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1177\/1352458520930620","volume":"27","author":"A Ghezzi","year":"2021","unstructured":"Ghezzi A, Amato MP, Edan G et al (2021) The introduction of new medications in pediatric multiple sclerosis: open issues and challenges. Mult Scler 27(3):479\u2013482","journal-title":"Mult Scler"},{"issue":"4","key":"8518_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1756285610371251","volume":"3","author":"A Ghezzi","year":"2010","unstructured":"Ghezzi A (2010) Therapeutic strategies in childhood multiple sclerosis. Ther Adv Neurol Disord 3(4):217\u2013228","journal-title":"Ther Adv Neurol Disord"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08518-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08518-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08518-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:40:24Z","timestamp":1764895224000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08518-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,4]]},"references-count":5,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["8518"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08518-8","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2025,10,4]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Ethical Grant is not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical grant"}},{"value":"Nothing to Declare.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}